Two local pharmaceutical firms have issued recalls for blood pressure medication after their drugs were found to contain potential carcinogens, the Food and Drug Administration (FDA) said, following similar recalls worldwide.
Taipei-based Synmosa Biopharma Corp (健喬信元醫藥生技) on Friday informed the agency that during a self-screening it had discovered that the active ingredient valsartan in its Vaks 80mg and Vaks 160mg tablets contained N-nitrosodimethylamine (NDMA), a substance suspected to increase the likelihood of cancer, the FDA said in a statement
The valsartan came from Tianyu Pharmaceutical Co (天宇), in China’s Zhejiang Province, and had the batch number 10230-160509, the agency said.
Photo provided by the Food and Drug Administration
The recall, which is to continue until June, affects about 660,000 million tablets produced by Synmosa in three batches, with the numbers B26541, B24691 and B22371, the agency said.
In addition, the FDA said it has found that Tianyu Pharmaceutical’s Valsartan was also used by Synpac-Kingdom Pharmaceutical Co (景德製藥), another Taiwanese pharmaceutical firm, to produce blood pressure medication.
The agency on Friday asked Synpac-Kingdom to recall its Disartan 80mg containing the ingredient, which would affect 577,000 tablets from two batches with the code numbers AGR098 and AGW118, it said.
The two firms aim to complete the recall by March 15, the FDA said.
The incident is the latest among several cases worldwide in which potentially tainted blood pressure medication has been recalled.
The US Food and Drug Administration in July and August last year announced recalls of blood pressure drugs containing valsartan that were contaminated with NDMA or a similar impurity, N-nitrosodiethylamine.
All of the recalled products had ingredients made in India or China.
FDA division head Hung Kuo-teng (洪國登) in December said that when the agency first heard of the potential problems in July, it began checking blood pressure drugs on the local market and asked drug makers to screen their own products for impurities.
The EU in summer and fall last year also launched global recalls of drugs after discovering that the valsartan they contained, which came from India, was contaminated, Hung said.
Seven of the 17 NT$10 million (US$311,604) winning receipts from the November-December uniform invoice lottery remain unclaimed as of today, the Ministry of Finance said, urging winners to redeem their prizes by May 5. The reminder comes ahead of the release of the winning numbers for the January-February lottery tomorrow. Among the unclaimed receipts was one for a NT$173 phone bill in Keelung, while others were for a NT$5,913 purchase at Costco in Taipei's Neihu District (內湖), a NT$49 purchase at a FamilyMart in New Taipei City's Tamsui District (淡水), and a NT$500 purchase at a tea shop in New Taipei City's
Taiwanese officials were shown the first of 66 F-16V fighter jets purchased by Taiwan from the United States, the Ministry of National Defense said yesterday, adding the aircraft has completed an initial flight test and is expected to be delivered later this year. A delegation led by Deputy Minister of National Defense Hsu Szu-chien (徐斯儉) visited Lockheed Martin’s F-16 C/D Block 70 (also known as F-16V) assembly line in South Carolina on March 16 to view the aircraft. The jet will undergo a final acceptance flight in the US before being delivered to Taiwan, the
The New Taipei Metro's Sanyin Line and the eastern extension of the Taipei Metro's Tamsui-Xinyi Line (Red Line) are scheduled to begin operations in June, the National Development Council said today. The Red Line, which terminates at Xiangshan Station, would be connected by the 1.4km extension to a new eastern terminal, Guangci/Fengtian Temple Station, while the Sanyin Line would link New Taipei City's Tucheng and Yingge stations via Sanxia District (三峽). The council gave the updates at a council meeting reviewing progress on public construction projects for this year. Taiwan's annual public infrastructure budget would remain at NT$800 billion (US$25.08 billion), with NT$97.3
Deliveries of delayed F-16V jets are expected to begin in September, Minister of National Defense Wellington Koo (顧立雄) said today, after senior defense officials visited the US last week. The US in 2019 approved a US$8 billion sale of Lockheed Martin F-16 jets to Taiwan, a deal that would take the nation’s F-16 fleet to more than 200 jets, but the project has been hit by issues including software problems. Koo appeared today before a meeting of the legislature’s Foreign Affairs and National Defense Committee, which is discussing different versions of the special defense budget this week. The committee is questioning officials today,
RSS